A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

出版年份 2010 全文链接

标题

作者

关键词

出版物

Volume 116, Issue 6, Pages 893-899

出版商

American Society of Hematology

发表日期

2010-05-04

DOI

10.1182/blood-2010-03-273151

参考文献

查看 4 条相关文献

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation